Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
Despite intensive research efforts, pancreatic ductal adenocarcinoma is still regarded as an aggressive and life-limiting malignancy. Combination chemotherapy regimens that underpin the current treatment approach in the advanced setting have led to incremental survival gains in recent years but have...
Saved in:
Main Authors: | Caroline Y. K. Fong, Emma Burke, David Cunningham, Naureen Starling |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2019/7135437 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma
by: Kai Tai Derek Yeung, PhD, FRCS, et al.
Published: (2024-09-01) -
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
by: Heng‐Chung Kung, et al.
Published: (2023-04-01) -
Identification of key regulators in pancreatic ductal adenocarcinoma using network theoretical approach.
by: Kankana Bhattacharjee, et al.
Published: (2025-01-01) -
A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
by: Vlad Herlea, et al.
Published: (2020-01-01) -
Nuclear Position and Shape Deformation of Chromosome 8 Territories in Pancreatic Ductal Adenocarcinoma
by: Sylvia Timme, et al.
Published: (2011-01-01)